Entities / Person
Patrick Soon-Shiong.
Chinese-American billionaire physician, CEO & philanthropist
- Reports this week
- 0
- Active events
- 0
- Connections
- 12
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
ASU established the Biodesign Institute, an academic unit, involving Patrick Soon-Shiong and NantWorks.Some support1 report
-
ImmunityBio received prior approval in the U.S. on July 8, 2025, and Patrick Soon-Shiong was noted as Founder and Executive Chairman.Speculative1 report
-
NantBioRenewables was named a finalist in an award announced by Reuters on August 12, 2025, alongside its founder's ecosystem.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Patrick Soon-Shiong this week
News at the entities that move Patrick Soon-Shiong most-
Los Angeles Times StructuralLos Angeles Times reports on political events involving Donald Trump.Moves Patrick Soon-Shiong
-
ImmunityBio StructuralImmunityBio must disclose its holdings in compliance with SEC filing requirements.Moves Patrick Soon-Shiong
-
Turkey OperationalAzerbaijan bans Turkish citizens and faces internal disputes while Isaac Herzog meets Ilham Aliyev in Baku.Moves Patrick Soon-Shiong
-
Saudi Arabia TransactionalMalaysia, Saudi Arabia, and Türkiye are noted as top Islamic finance markets, while Benin, Tanzania, Kenya, and Azerbaijan are highlighted as growing markets.Moves Patrick Soon-Shiong
-
Macau TransactionalIn 2019, protests challenged Xi Jinping in Macau, while Donald Trump backed the demonstrators against Beijing.Moves Patrick Soon-Shiong
Connections
The 7 strongest of 12, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
NantWorks Structural
Patrick Soon-Shiong founded NantWorks in 2011.
-
Los Angeles Times Structural
Patrick Soon-Shiong owns the Los Angeles Times, a relationship established by acquisition in 2018.
-
ImmunityBio Structural
Patrick Soon-Shiong serves as the Founder and Executive Chairman of ImmunityBio.
-
Saudi Arabia Transactional
A drug associated with Patrick Soon-Shiong has successfully gained acceptance for sale within the Saudi Arabian market.
-
San Diego Union-Tribune Structural
Patrick Soon-Shiong acquired the San Diego Union-Tribune in 2018.
-
Turkey Operational
Business meetings discussed optimism regarding potential market expansion into Turkey.
-
Macau Transactional
A drug associated with Patrick Soon-Shiong received regulatory acceptance for sale in Macau.
History
Events by the month they beganSeptember 2026
1 eventJune 2026
3 events- ASU established the Biodesign Institute, an academic unit, involving Patrick Soon-Shiong and NantWorks.
- ImmunityBio received prior approval in the U.S. on July 8, 2025, and Patrick Soon-Shiong was noted as Founder and Executive Chairman.
- NantBioRenewables was named a finalist in an award announced by Reuters on August 12, 2025, alongside its founder's ecosystem.